FI111382B - Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning - Google Patents
Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning Download PDFInfo
- Publication number
- FI111382B FI111382B FI933001A FI933001A FI111382B FI 111382 B FI111382 B FI 111382B FI 933001 A FI933001 A FI 933001A FI 933001 A FI933001 A FI 933001A FI 111382 B FI111382 B FI 111382B
- Authority
- FI
- Finland
- Prior art keywords
- substance
- lactic acid
- acid bacterial
- culture
- antigastrite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/854—Lactobacillus acidophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- General Preparation And Processing Of Foods (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Fire-Extinguishing Compositions (AREA)
- Treating Waste Gases (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
Claims (9)
1. Förfarande för att ästadkomma en biologiskt ren odling av en mjölksyrabakteriestam, kännetecknat av, att en Lactobacillus johnsonii-stam CNCM 5 1-1225 väljs som nämnda mjölksyrabakterie, och att Lactobacillus johnsonii CNCM 1-1225 därefter odlas och isoleras.
2. Förfarande för att ästadkomma en antigastrit-substans och/eller en magsärsmotverkande substans, kännetecknat av, att antigastrit-substansen 10 och/eller den magsärsmotverkande substansen framställs genom att odla en biologiskt ren Lactobacillus johnsonii - stam CNCM 1-1225, som valts för att den har förmägan att producera denna nämnda substans.
3. Förfarande för att ästadkomma en antigastrit-substans och/eller en mag-15 särsmotverkande substans enligt patentkrav 2, kännetecknat av, att antigastrit-substansen och/eller den magsärsmotverkande substansen utsöndras i sitt odlingsmedium genom att odla den biologiskt rena Lactobacillus johnsonii -stammen CNCM 1-1225 i nämnda odlingsmedium. 20
4. Förfarande enligt patentkrav 2 eller 3, kännetecknat av, att supernatant- fasen separeras frän nämnda odlingsmedium med konventionella medel efter det att den biologiskt rena Lactobacillus johnsonii -stammen CNCM 1-1225 enligt patentkrav 2 eller 3 har odlats i nämnda odlingsmedium. 25
5. Förfarande enligt nägot av patentkraven 2-4, kännetecknat av, att nämnda antigastrit-substans och/eller magsärsmotverkande substans isoleras genom extrahering frän supernatantfasen enligt patentkrav 4.
6. Förfarande för framställning av en livsmedelssammansättning, känne-30 tecknat av, att en biologiskt ren odling av en mjölksyrabakteriestam, vilken mjölksyrabakteriestam har förmägan attförtränga Helicobacter pylori frän 111382 tarm- eller magceller, eller en sädan mjölksyrabakteriestams odlingssuperna-tant eller frän odlingssupernatanten extraherad substans, varvid nämnda odlingssupernatant eller nämnda extraherade substans har förmägan att för-tränga Helicobacter pylori frän tarm- eller magceller, förenas med en ätbar 5 bärare, varvid nämnda livsmedelssammansättning erhälls.
7. Förfarande för framställning av en läkemedelssammansättning, känne-tecknat av, att en biologiskt ren odling av en mjölksyrabakteriestam, vilken mjölksyrabakteriestam har förmägan att förtränga Helicobacter pylori frän 10 tarm- eller magceller, eller en sädan mjölksyrabakteriestams odlingssupernatant eller frän odlingssupernatanten extraherad substans, varvid nämnda odlingssupernatant eller nämnda extraherade substans har förmägan att förtränga Helicobacter pylori frän tarm- eller magceller, förenas med en ätbar bärare, varvid nämnda läkemedelssammansättning erhälls. 15
8. Förfarande enligt patentkrav 6 eller 7, kännetecknat av, att en Lactobacillus johnsonii-stam CNCM 1-1225 väljs som mjölksyrabakteriestam.
9. Förfarande enligt nägot av patentkraven 6-8, kännetecknat av, att den 20 ätbara bäraren är en farmaceutiskt godtagbar bärare och/eller ett livsmedel säsom surgjord mjölk, speciellt yoghurt eller mjölkbaserad pulverformulering.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92810515A EP0577903B1 (fr) | 1992-07-06 | 1992-07-06 | Agent antigastrite |
EP92810515 | 1992-07-06 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI933001A0 FI933001A0 (fi) | 1993-06-30 |
FI933001A FI933001A (fi) | 1994-01-07 |
FI111382B true FI111382B (sv) | 2003-07-15 |
Family
ID=8211947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI933001A FI111382B (sv) | 1992-07-06 | 1993-06-30 | Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning |
Country Status (20)
Country | Link |
---|---|
US (1) | US5578302A (sv) |
EP (1) | EP0577903B1 (sv) |
JP (1) | JP2672247B2 (sv) |
AT (1) | ATE161181T1 (sv) |
AU (1) | AU668397B2 (sv) |
CA (1) | CA2099855C (sv) |
CZ (1) | CZ284196B6 (sv) |
DE (1) | DE69223615T2 (sv) |
DK (1) | DK0577903T3 (sv) |
ES (1) | ES2111625T3 (sv) |
FI (1) | FI111382B (sv) |
GR (1) | GR3025971T3 (sv) |
HU (1) | HU218350B (sv) |
IE (1) | IE930481A1 (sv) |
NO (1) | NO307984B1 (sv) |
NZ (1) | NZ248056A (sv) |
PL (1) | PL178193B1 (sv) |
RO (1) | RO117832B1 (sv) |
RU (1) | RU2129431C1 (sv) |
SK (1) | SK280661B6 (sv) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
JP3004890B2 (ja) * | 1995-03-28 | 2000-01-31 | 雪印乳業株式会社 | 病原体感染防御剤 |
US5753622A (en) * | 1995-05-10 | 1998-05-19 | University Technologies International, Inc. | Use of epidermal growth factor as a gastrointestinal therapeutic agent |
FI104465B (sv) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa |
AUPN698495A0 (en) * | 1995-12-06 | 1996-01-04 | Pharma Pacific Pty Ltd | Improved therapeutic formulation and method |
EP1728855A1 (en) * | 1996-11-29 | 2006-12-06 | Bio-K Plus International, Inc. | Lactic ferment comprising a particular strain of lactobacillus acidopuilus and use thereof |
WO1998023727A1 (en) * | 1996-11-29 | 1998-06-04 | Bio K + International Inc. | Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof |
DE69712915T2 (de) * | 1996-12-23 | 2002-09-12 | Societe Des Produits Nestle S.A., Vevey | Quark |
JP3430853B2 (ja) | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
WO1999002042A2 (fr) | 1997-07-05 | 1999-01-21 | Societe Des Produits Nestle S.A. | Dessert congele contenant des bacteries lactiques et des fibres fermentescibles |
WO1999049876A2 (en) * | 1998-03-31 | 1999-10-07 | Abbott Laboratories | Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof |
FR2785190B1 (fr) * | 1998-10-30 | 2001-01-26 | Lacteol Du Docteur Boucard Lab | Composition anti-bacterienne |
IL145080A0 (en) | 1999-03-11 | 2002-06-30 | Nestle Sa | Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
EP1034787A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
EP1034788A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
JP3046303B1 (ja) | 1999-06-24 | 2000-05-29 | 明治乳業株式会社 | Helicobacterpylori除菌性飲食品 |
CA2378426C (en) | 1999-08-05 | 2010-03-23 | Societe Des Produits Nestle S.A. | Bifidobacteria capable of preventing diarrhea |
TR200200301T2 (tr) | 1999-08-05 | 2004-12-21 | Societe Des Produits Nestle S.A. | Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler |
EP1110555A1 (fr) * | 1999-12-22 | 2001-06-27 | Societe Des Produits Nestle S.A. | Agent anti-adhesion de la flore pathogene de la peau |
ATE542434T1 (de) * | 2000-01-18 | 2012-02-15 | Nestle Sa | Haustierfutterzusammensetzung zur behandlung der helicobacter spezies in haustieren |
EP1148064A1 (en) * | 2000-04-17 | 2001-10-24 | Vrije Universiteit Brussel | Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori |
KR100449598B1 (ko) * | 2000-12-08 | 2004-09-18 | (주) 피엘바이오 | 헬리코박터 필로리의 활성을 억제하는 유산균 |
EP1260227A1 (en) * | 2001-05-23 | 2002-11-27 | Societe Des Produits Nestle S.A. | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
SE0103695D0 (sv) | 2001-11-07 | 2001-11-07 | Thomas Boren | A novel non-antibiotic strategy against OGIP infections based on a cereal product |
ATE402993T1 (de) | 2002-06-28 | 2008-08-15 | Puleva Biotech Sa | Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung |
US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
WO2005079210A2 (en) * | 2003-12-04 | 2005-09-01 | Biofilms Strategies, Inc. | Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US20060115468A1 (en) * | 2004-11-26 | 2006-06-01 | Kara Morrison | Dietary supplement for treating and preventing gastrointestinal disorders |
MX2007012697A (es) | 2005-04-13 | 2008-01-14 | Nestec Sa | Formula para infantes con probioticos. |
BRPI0611492B1 (pt) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
PL1981516T3 (pl) | 2006-01-27 | 2019-03-29 | Dupont Nutrition Biosciences Aps | Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom |
CN101420965B (zh) | 2006-02-15 | 2013-08-07 | 雀巢产品技术援助有限公司 | 长双歧杆菌在制备预防和治疗炎症的药物中的用途 |
MY149913A (en) | 2006-03-07 | 2013-10-31 | Nestec Sa | Synbiotic mixture |
CN101711158A (zh) | 2007-02-01 | 2010-05-19 | 爱默思公司 | 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法 |
EP1974743A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
EP1974735A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Reduction of risk of diarrhoea |
EP1992351B1 (en) * | 2007-05-18 | 2016-05-11 | Nestec S.A. | Lactobacillus johnsonii for prevention of postsurgical infection |
EP2072052A1 (en) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
CA2712207A1 (en) | 2008-01-24 | 2009-07-30 | Nestec S.A. | Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule |
PT2265135T (pt) | 2008-03-14 | 2018-02-21 | Nestec Sa | Mistura simbiótica |
EP2127661A1 (en) | 2008-05-27 | 2009-12-02 | Nestec S.A. | Probiotics to improve gut microbiotica |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
EP2147678A1 (en) | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
RU2556124C2 (ru) * | 2009-05-11 | 2015-07-10 | Нестек С.А. | Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
AU2010329990B2 (en) | 2009-12-08 | 2015-07-16 | Nestec S.A. | Infant formula with probiotics and milk fat globule membrane components |
EP2397145A1 (en) * | 2010-06-18 | 2011-12-21 | Nestec S.A. | L. johnsonii La1, B. longum NCC2705 and immune disorders |
CN104127443B (zh) * | 2014-07-25 | 2017-11-10 | 吉林省农业科学院 | 一种植物乳杆菌c88与人参多糖组合物的制备方法 |
EP4003061B1 (en) | 2019-07-23 | 2024-04-24 | FrieslandCampina Nederland B.V. | Nutritional composition comprising milk fat and immunoglobulin |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953609A (en) * | 1974-02-06 | 1976-04-27 | Microlife Technics, Inc. | Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628 |
JPS52102419A (en) * | 1976-02-23 | 1977-08-27 | Seikenkai | Lactic acid producing bacillus preparation |
CH637297A5 (fr) * | 1978-12-05 | 1983-07-29 | Nestle Sa | Microbille comprenant un microorganisme et son procede de fabrication. |
FI59925C (fi) * | 1980-01-11 | 1981-11-10 | Esko Viljo Nurmi | Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae |
US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
JPS62104552A (ja) * | 1985-10-31 | 1987-05-15 | Morinaga Milk Ind Co Ltd | 飼料組成物 |
US4980164A (en) * | 1986-10-02 | 1990-12-25 | Bio Techniques Laboratories, Inc. | Strains of lactobacillus for enhancing feed conversion efficiency |
US4946791A (en) * | 1986-10-02 | 1990-08-07 | Bio Techniques Laboratories, Inc. | Novel strain of Lactobacillus acidophilus |
US4921857A (en) * | 1987-09-18 | 1990-05-01 | Merck & Co., Inc. | 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof |
DK686187D0 (da) * | 1987-12-23 | 1987-12-23 | Hansens Chr Bio Syst | Veterinaert praeparat |
SE465206B (sv) * | 1989-12-22 | 1991-08-12 | Eva Grahn | Farmaceutisk beredning foer bekaempning av patogena tarmbakterier |
US5116821A (en) * | 1990-11-20 | 1992-05-26 | The Procter & Gamble Company | Sulfated glyceroglucolipids as inhibitors of bacterial adherence |
US5229380A (en) * | 1991-06-28 | 1993-07-20 | Harris Richard Y | Method for treating helicobacter pylori gastritis |
US5256425A (en) * | 1991-08-19 | 1993-10-26 | Bio Techniques Laboratories, Inc. | Antibiotic resistant strain of lactobacillus acidophilus |
JPH0559038A (ja) * | 1991-09-06 | 1993-03-09 | Terumo Corp | チオウレア誘導体及びこれを含有する医薬製剤 |
-
1992
- 1992-07-06 ES ES92810515T patent/ES2111625T3/es not_active Expired - Lifetime
- 1992-07-06 EP EP92810515A patent/EP0577903B1/fr not_active Expired - Lifetime
- 1992-07-06 DK DK92810515.4T patent/DK0577903T3/da active
- 1992-07-06 AT AT92810515T patent/ATE161181T1/de active
- 1992-07-06 DE DE69223615T patent/DE69223615T2/de not_active Expired - Lifetime
-
1993
- 1993-06-25 IE IE048193A patent/IE930481A1/en not_active IP Right Cessation
- 1993-06-28 AU AU41588/93A patent/AU668397B2/en not_active Ceased
- 1993-06-28 HU HU9301884A patent/HU218350B/hu not_active IP Right Cessation
- 1993-06-30 FI FI933001A patent/FI111382B/sv not_active IP Right Cessation
- 1993-07-01 PL PL93299543A patent/PL178193B1/pl not_active IP Right Cessation
- 1993-07-01 NO NO932407A patent/NO307984B1/no not_active IP Right Cessation
- 1993-07-02 NZ NZ248056A patent/NZ248056A/en not_active IP Right Cessation
- 1993-07-02 CZ CZ931342A patent/CZ284196B6/cs not_active IP Right Cessation
- 1993-07-05 RO RO93-00946A patent/RO117832B1/ro unknown
- 1993-07-05 CA CA002099855A patent/CA2099855C/en not_active Expired - Lifetime
- 1993-07-06 RU RU93046323A patent/RU2129431C1/ru not_active IP Right Cessation
- 1993-07-06 SK SK711-93A patent/SK280661B6/sk unknown
- 1993-07-06 JP JP5166717A patent/JP2672247B2/ja not_active Expired - Fee Related
-
1995
- 1995-04-28 US US08/430,297 patent/US5578302A/en not_active Expired - Lifetime
-
1998
- 1998-01-21 GR GR980400141T patent/GR3025971T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI933001A (fi) | 1994-01-07 |
US5578302A (en) | 1996-11-26 |
CA2099855A1 (en) | 1994-01-07 |
EP0577903A1 (fr) | 1994-01-12 |
JP2672247B2 (ja) | 1997-11-05 |
EP0577903B1 (fr) | 1997-12-17 |
SK280661B6 (sk) | 2000-05-16 |
GR3025971T3 (en) | 1998-04-30 |
CZ284196B6 (cs) | 1998-09-16 |
SK71193A3 (en) | 1994-06-08 |
JPH0698782A (ja) | 1994-04-12 |
HUT66632A (en) | 1994-12-28 |
FI933001A0 (fi) | 1993-06-30 |
IE930481A1 (en) | 1994-01-12 |
CA2099855C (en) | 1999-06-15 |
DE69223615D1 (de) | 1998-01-29 |
AU668397B2 (en) | 1996-05-02 |
CZ134293A3 (en) | 1994-01-19 |
ATE161181T1 (de) | 1998-01-15 |
RU2129431C1 (ru) | 1999-04-27 |
ES2111625T3 (es) | 1998-03-16 |
HU9301884D0 (en) | 1993-10-28 |
RO117832B1 (ro) | 2002-08-30 |
NO307984B1 (no) | 2000-07-03 |
DE69223615T2 (de) | 1998-04-09 |
HU218350B (hu) | 2000-08-28 |
PL299543A1 (en) | 1994-02-21 |
NO932407L (no) | 1994-01-07 |
NZ248056A (en) | 1995-08-28 |
AU4158893A (en) | 1994-01-13 |
NO932407D0 (no) | 1993-07-01 |
DK0577903T3 (da) | 1998-04-06 |
PL178193B1 (pl) | 2000-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI111382B (sv) | Förfaranden för åstadkommande av antigastrit-substans och biologiskt ren odling av en mjölksyrabakteriestam samt förfaranden för framställning av livsmedelssammansättning och läkemedelssammansättning | |
FI111650B (sv) | Förfarande för att producera en biologiskt ren odling av mjölksyrabakterier | |
US7767430B2 (en) | Bifidobacteria preventing diarrhea caused by pathogenic bacteria | |
US4746512A (en) | Anticariogenic or antiperiodontitic agent | |
AU779789B2 (en) | Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses | |
Ahn et al. | Characterization of Lactobacillus acidophilus isolated from piglets and chicken | |
US6998119B1 (en) | Feed composition containing Bifidobacterium CNCM 1-2168 capable of preventing diarrhea | |
US20070134220A1 (en) | Lactobacillus fermentum strain and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |